Nephrologists in Egypt use serum creatinine and urine output criteria suggested by Kidney Disease Improving Global Outcomes to diagnose AKI.7 Newer biomarkers, such as cystatin C and neutrophil gelatinase-associated lipocalin, are used for research purposes only in AKI. Here, CST3 is linked to kidney disorder.